The Low Platelet Count at the Start of Atezolizumab Plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma Predicts Deteriorated Liver Function at the Time of Disease Progression Thereafter: A Multicenter Analysis

Ryo Sato, Takanori Suzuki, Kentaro Matsuura, Daisuke Kato, Katsumi Hayashi, Kohei Okayama, Fumihiro Okumura, Satoshi Sobue, Atsunori Kusakabe, Izumi Hasegawa, Kiyoto Narita, Tsutomu Mizoshita, Yoshihide Kimura, Hiromu Kondo, Hisayo Kojima, Kazuki Hayashi, Atsushi Ozasa, Hayato Kawamura, Kei Fujiwara, Shunsuke Nojiri, Hiromi Kataoka, Unknown

Open source

DOI: 10.1111/hepr.70101
Published: 2025-12-18
Container: Hepatology Research
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/hepr.70101,
  title = {The Low Platelet Count at the Start of Atezolizumab Plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma Predicts Deteriorated Liver Function at the Time of Disease Progression Thereafter: A Multicenter Analysis},
  author = {Ryo Sato and Takanori Suzuki and Kentaro Matsuura and Daisuke Kato and Katsumi Hayashi and Kohei Okayama and Fumihiro Okumura and Satoshi Sobue and Atsunori Kusakabe and Izumi Hasegawa and Kiyoto Narita and Tsutomu Mizoshita and Yoshihide Kimura and Hiromu Kondo and Hisayo Kojima and Kazuki Hayashi and Atsushi Ozasa and Hayato Kawamura and Kei Fujiwara and Shunsuke Nojiri and Hiromi Kataoka and Unknown},
  year = {2025},
  journal = {Hepatology Research},
  doi = {10.1111/hepr.70101},
  url = {https://doi.org/10.1111/hepr.70101}
}

RIS

TY  - JOUR
TI  - The Low Platelet Count at the Start of Atezolizumab Plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma Predicts Deteriorated Liver Function at the Time of Disease Progression Thereafter: A Multicenter Analysis
AU  - Ryo Sato
AU  - Takanori Suzuki
AU  - Kentaro Matsuura
AU  - Daisuke Kato
AU  - Katsumi Hayashi
AU  - Kohei Okayama
AU  - Fumihiro Okumura
AU  - Satoshi Sobue
AU  - Atsunori Kusakabe
AU  - Izumi Hasegawa
AU  - Kiyoto Narita
AU  - Tsutomu Mizoshita
AU  - Yoshihide Kimura
AU  - Hiromu Kondo
AU  - Hisayo Kojima
AU  - Kazuki Hayashi
AU  - Atsushi Ozasa
AU  - Hayato Kawamura
AU  - Kei Fujiwara
AU  - Shunsuke Nojiri
AU  - Hiromi Kataoka
AU  - Unknown
PY  - 2025
JO  - Hepatology Research
DO  - 10.1111/hepr.70101
UR  - https://doi.org/10.1111/hepr.70101
ER  -

APA

Sato, R., Suzuki, T., Matsuura, K., Kato, D., Hayashi, K., Okayama, K., Okumura, F., Sobue, S., Kusakabe, A., Hasegawa, I., Narita, K., Mizoshita, T., Kimura, Y., Kondo, H., Kojima, H., Hayashi, K., Ozasa, A., Kawamura, H., Fujiwara, K., Nojiri, S., Kataoka, H., & Unknown (2025). The Low Platelet Count at the Start of Atezolizumab Plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma Predicts Deteriorated Liver Function at the Time of Disease Progression Thereafter: A Multicenter Analysis. Hepatology Research. https://doi.org/10.1111/hepr.70101

Source records

crossref · retrieved 2026-09-27T02:37:53.301Z